TY - JOUR
T1 - Comparison of CD8+ T-cell subsets in HIV-infected rapid progressor children versus non-rapid progressor children
AU - Paul, Mary E.
AU - Shearer, William T.
AU - Kozinetz, Claudia A.
AU - Lewis, Dorothy E.
N1 - Funding Information:
Sponsored by National Institutes of Health Grants AI39131, AI36211, and RR-00188 GCRC, and by the Pediatric AIDS Fund and Immunology Research Fund, Texas Children’s Hospital, Houston.
PY - 2001
Y1 - 2001
N2 - Background: CD8+ T-cell subsets have not been adequately described in HIV-infected (HIV+) children classified with respect to disease progression as rapid-progressors (RPs) and non-rapid progressors (non-RPs). Objective: The purpose of this investigation was to determine the distribution of CD8+ T-cell subsets in HIV+ children and correlate the findings with degree of immunosuppression and HIV viral burden. Methods: By means of 3-color flow cytometry, percentages of CD38+DR+, cd28+, and CD57+ CD8+ T-cell subsets were examined in RP (n = 15) and non-RP (n = 36) HIV+ children and in HIV-exposed but uninfected (n = 11) and HIV-unexposed (n = 8) children. The CD8+T-cell subsets were correlated with mean CD4+T-cell percentages and HIV RNA levels. Analysis of covariance was used for group comparisons for the control of the covariate of age. Results: The HIV-exposed and HIV-unexposed controls were not different from each other in CD8+T-cell subset percentages, except that the DR-CD38+CD8+ T-cell percentages were higher in the exposed controls than in the unexposed controls. RPs had a higher mean percentage of DR+CD38+CD8+ T cells than non-RPs and both control groups, and RPs had higher viremia than non-RPs. CD38+CD8+ T-cell percentages did not correlate with viral burden as it has been seen to do in HIV+ adults. Percentages of CD28+CD8+ T cells were lower in HIV-infected children than in controls. There was a positive correlation of percentage of CD28+CD57-CD8+ T cells with CD4+ T-cell percentages in each HIV-infected group. Conclusion: CD8+ T cells become activated (dual expression of DR and CD38) and lose CD28, some acquiring CD57, in relation to rapidity of disease progression in pediatric HIV infection.
AB - Background: CD8+ T-cell subsets have not been adequately described in HIV-infected (HIV+) children classified with respect to disease progression as rapid-progressors (RPs) and non-rapid progressors (non-RPs). Objective: The purpose of this investigation was to determine the distribution of CD8+ T-cell subsets in HIV+ children and correlate the findings with degree of immunosuppression and HIV viral burden. Methods: By means of 3-color flow cytometry, percentages of CD38+DR+, cd28+, and CD57+ CD8+ T-cell subsets were examined in RP (n = 15) and non-RP (n = 36) HIV+ children and in HIV-exposed but uninfected (n = 11) and HIV-unexposed (n = 8) children. The CD8+T-cell subsets were correlated with mean CD4+T-cell percentages and HIV RNA levels. Analysis of covariance was used for group comparisons for the control of the covariate of age. Results: The HIV-exposed and HIV-unexposed controls were not different from each other in CD8+T-cell subset percentages, except that the DR-CD38+CD8+ T-cell percentages were higher in the exposed controls than in the unexposed controls. RPs had a higher mean percentage of DR+CD38+CD8+ T cells than non-RPs and both control groups, and RPs had higher viremia than non-RPs. CD38+CD8+ T-cell percentages did not correlate with viral burden as it has been seen to do in HIV+ adults. Percentages of CD28+CD8+ T cells were lower in HIV-infected children than in controls. There was a positive correlation of percentage of CD28+CD57-CD8+ T cells with CD4+ T-cell percentages in each HIV-infected group. Conclusion: CD8+ T cells become activated (dual expression of DR and CD38) and lose CD28, some acquiring CD57, in relation to rapidity of disease progression in pediatric HIV infection.
KW - HIV disease progression
KW - Pediatric HIV-1 infection
UR - http://www.scopus.com/inward/record.url?scp=0034904179&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034904179&partnerID=8YFLogxK
U2 - 10.1067/mai.2001.117179
DO - 10.1067/mai.2001.117179
M3 - Article
C2 - 11496243
AN - SCOPUS:0034904179
VL - 108
SP - 258
EP - 264
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 2
M1 - 40335
ER -